Bioprocessing and biomanufacturing focus
Latest
ArticleImplementing horizontal recycling for pharmaceutical release liners
Closed-loop backing paper recycling enables manufacturers to convert release liner waste into circular materials without modifications to existing printers or labellers, meanwhile ensuring EU packaging waste regulation compliance.
ArticleTroubleshooting capping defects in brittle tablet formulations
Cam-driven technology optimises the compaction process by maintaining consistent tablet hardness across turret speeds, enabling robust, scalable manufacturing of capping-prone blends.
ArticleWhat Annex 22 spells for AI in GMP manufacturing
Europeâs first dedicated framework for artificial intelligence in GMP manufacturing is close to finalisation and it is more demanding and more consequential than many manufacturers may currently appreciate.
Featured
Article
Day three preview: the Future of Bio/Pharma Analysis Virtual Summit 2026
Pharmaceutical manufacturing takes centre stage on Day three of The Future of Bio/Pharmaceutical Analysis Virtual Summit 2026 as speakers examine how digital technologies, artificial intelligence and advanced production methods are reshaping what is possible in the field.
Article
Staying competitive within the evolving CDMO model
CEO of Lupin Manufacturing Solutions, shares his perspective on what differentiates credible CDMO entrants as pharmaceutical pipelines shift towards structurally complex molecules, the scientific imperatives shaping oncology and peptide manufacturing and the talent challenge that he believes will define competitive positioning in the decade ahead.
Webinars
- Previous
- Next
Whitepapers
- Previous
- Next
Join now
Unlock exclusive industry insights
- Bookmark articles and resources to access anytime
- Enjoy free access to industry leading resources, webinars and insights
- Stay informed with the latest news and breakthroughs in drug discovery
- Receive updates and recommendations tailored to your research interests
More bioprocessing and biomanufacturing
- Article
What Annex 22 spells for AI in GMP manufacturing
Europeâs first dedicated framework for artificial intelligence in GMP manufacturing is close to finalisation and it is more demanding and more consequential than many manufacturers may currently appreciate.
ArticleStaying competitive within the evolving CDMO model
CEO of Lupin Manufacturing Solutions, shares his perspective on what differentiates credible CDMO entrants as pharmaceutical pipelines shift towards structurally complex molecules, the scientific imperatives shaping oncology and peptide manufacturing and the talent challenge that he believes will define competitive positioning in the decade ahead.
ArticleThermal assurance as an operating model: why the pharmaceutical cold chain must evolve beyond visibility
Real-time monitoring has become standard practice in temperature-controlled distribution. The differentiator now is whether organisations can convert signals into decisions early enough to prevent excursions, reduce waste and strengthen resilience. As Vijay Paliwal, Vice President, Global Advanced Solutions & Customer Experience at Cold Chain Technologies explains, that shift is driving a new operating model for cold chain management: thermal assurance.
ArticleMedicines as strategic assets: the new politics of pharma supply
Ahead of CPHI Americas in June, Sherma Ellis Daal explores how informed, cross-sector dialogue in the pharmaceutical supply chain can help navigate an increasingly complex global system.
ArticleBreaking the biomanufacturing mould: a patient-centric CDMO approach
Helen Bickley, Chief Quality Officer, FUJIFILM Biotechnologies reveals a new agile approach to biologics production that adopts a modular strategy for greater flexibility and ease.
ReportPharma Horizons: Cell and Gene Therapy
Cell and gene therapies are transforming modern medicine, offering new hope for patients with complex and previously untreatable diseases. As innovation advances, the industry must overcome challenges in manufacturing, regulation and scalability to unlock the full potential of these groundbreaking therapies.
OpinionReal-time Raman spectroscopy closes bioprocess control measurement gap
Manual sampling cycles leave bioreactor control decisions hours behind culture dynamics. Process Raman spectroscopy offers continuous, real-time measurement of critical parameters, enabling true closed-loop control in perfusion and continuous bioprocessing applications where measurement lag directly impacts yield and product quality.
OpinionProcess Raman spectroscopy: closing biomanufacturingâs measurement infrastructure gap
The biopharmaceutical industry has embraced Pharma 4.0 concepts, but the measurement infrastructure required to realise autonomous facilities and continuous bioprocessing remains underdeveloped. Process Raman spectroscopy offers continuous, non-destructive monitoring at frequencies aligned with cell culture dynamics, bridging the gap between control system capabilities and available data.
ArticleEuropean Pharmaceutical Review Issue 1 (2026): Environmental Monitoring In-Depth Focus
This In-Depth Focus explores how BPCs, RMMs and AI-enabled analytics are being evaluated as a tool to enhance aseptic manufacturing, bioburden testing and monitoring.
ArticleRaman spectroscopy market reaches $2.35bn driven by pharma
A recent market report projecting the combined NIR and Raman spectroscopy sector will reach $2.35 billion in 2026 underscores the rapid adoption of vibrational spectroscopy across biopharmaceutical manufacturing, with AI-enhanced Raman tools increasingly being deployed for real-time quality control.
ArticleEuropean Pharmaceutical Review Issue 1 2026
EPR Issue 1 includes articles on manufacturing, drug delivery, environmental monitoring, analytical techniques and more.
ArticleGaelic Labs: Pharma is increasingly focused on supply chain security
General Manager Brian Morrissey discusses his companyâs acquisition of fellow Beta-Lactam manufacturer Athlone Laboratories and its implications for an evolving industry.
ArticleOptimising the downstream process in lentiviral vector manufacturing
Sartorius BIA Separations illustrates a promising alternative approach for efficient lentiviral vector purification that delivers a scalable, GMP-ready biomanufacturing solution.
ReportPharma Horizons: Trends in Pharmaceutical Manufacturing
EPRâs 2026 pharma manufacturing trends report covers the key developments in supply chain, quality, drug development, new modalities and beyond.
ArticleThe case for outsourcing water for injection
Essential for any medicine that must be sterile and safe for injection, ROISâ Miguel Ăngel Ortega SĂĄnchez presents the case for outsourcing WFI production to a trusted partner.